药品注册申请号:204717
申请类型:ANDA (仿制药申请)
申请人:IMPAX LABS INC
申请人全名:IMPAX LABORATORIES INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 10MG No No AB 2018/05/07 2018/05/07 Prescription
002 CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 20MG No No AB 2018/05/07 Prescription
003 CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 40MG No No AB 2018/05/07 Prescription
004 CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 80MG No No AB 2018/05/07 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2018/05/07 ORIG-1(原始申请) Approval STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:CARVEDILOL PHOSPHATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:10MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022012 001 NDA COREG CR CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 10MG Discontinued Yes No AB 2006/10/20 WAYLIS THERAP
090132 001 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 10MG Prescription No No AB 2017/10/25 SUN PHARM INDUSTRIES
204717 001 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 10MG Prescription No No AB 2018/05/07 IMPAX LABS INC
活性成分:CARVEDILOL PHOSPHATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:20MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022012 002 NDA COREG CR CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 20MG Discontinued Yes No AB 2006/10/20 WAYLIS THERAP
090132 002 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 20MG Prescription No No AB 2017/10/25 SUN PHARM INDUSTRIES
204717 002 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 20MG Prescription No No AB 2018/05/07 IMPAX LABS INC
活性成分:CARVEDILOL PHOSPHATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:40MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022012 003 NDA COREG CR CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 40MG Discontinued Yes No AB 2006/10/20 WAYLIS THERAP
090132 003 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 40MG Prescription No Yes AB 2017/10/25 SUN PHARM INDUSTRIES
204717 003 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 40MG Prescription No No AB 2018/05/07 IMPAX LABS INC
活性成分:CARVEDILOL PHOSPHATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:80MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022012 004 NDA COREG CR CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 80MG Discontinued Yes No AB 2006/10/20 WAYLIS THERAP
090132 004 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription No No AB 2017/10/25 SUN PHARM INDUSTRIES
204717 004 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription No No AB 2018/05/07 IMPAX LABS INC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database